First Three Children to Commence Treatment With Ryoncil®
Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...
We lost our children in horrific circumstances – so we did something about it
Candace Lightner and Figen Murray have lived out every parent’s worst nightmare – the loss of a child. To compound their ...